Literature DB >> 25901408

The current status of MRI in 
prostate cancer.

Kesley Pedler1, Yu Xuan Kitzing, Celi Varol, Mohan Arianayagam.   

Abstract

BACKGROUND: The diagnosis and treatment of prostate cancer is a controversial topic. Until recently there has not been a reliable imaging mo-dality for identification of cancer within the prostate. New evidence suggests that multiparametric magngenetic resonance im-aging (MRI) has the potential to improve the diagnosis and treatment of prostate cancer.
OBJECTIVE: This article explains the potential roles for multiparametric MRI in the diagnosis and treatment of prostate cancer. DISCUSSION: Multiparametric MRI can help identify regions which may represent clinically significant prostate cancer. MRI may also be used to guide varying prostate cancer treatment modalities. An experienced radiologist and adequately powered MRI scanner are es-sential. Multiparametric MRI in the hands of an experienced uroradiology team is emerging as a useful tool in the diagnosis and treatment of prostate cancer however this technology is still in its infancy and requires further evaluation. At this time prostate MRI should only be ordered by the treating urologist.

Entities:  

Mesh:

Year:  2015        PMID: 25901408

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  2 in total

1.  A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: trends in clinical presentation and management of the disease.

Authors:  Rasa Ruseckaite; Kerri Beckmann; Michael O'Callaghan; David Roder; Kim Moretti; Jeremy Millar; Sue Evans
Journal:  BMC Cancer       Date:  2016-08-05       Impact factor: 4.430

2.  Improving the detection rate of prostate cancer in the gray zone of PI-RADS v2 and serum tPSA by using prostate-specific antigen-age volume.

Authors:  Yuan-Fei Lu; Qian Zhang; Hai-Yan Chen; Jie-Yu Chen; Yao Pan; Cong-Cong Xu; Jian-Xia Xu; Ri-Sheng Yu
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.